Infectious diseases pose a significant threat to global health. Early detection and accurate diagnosis are crucial for containing outbreaks, guiding treatment decisions, and preventing transmission. Clinical diagnostic testing plays a vital role in managing infectious diseases effectively by identifying causative agents such as bacteria, viruses, parasites, or fungi.
Timely and accurate diagnostic testing not only improves patient outcomes but also informs public health initiatives and targeted interventions. This necessity becomes more apparent during outbreaks or pandemics, like COVID-19, when rapid testing is essential for identifying cases, implementing containment measures, and allocating resources. Diagnostic testing provides reliable data for evidence-based decision-making, crucial for mitigating the impact of infectious diseases on individuals and communities.
Showing 1–9 of 11 results
The BeingBio C-Reactive Protein (CRP) Fluorescence Immunoassay (FIA) Test is a rapid and reliable point-of-care diagnostic tool designed to measure CRP levels in human serum, plasma, or whole blood. This easy-to-use lateral flow test provides accurate, quantitative results in just 3 minutes, using the innovative Multi-channels FIA system.
Healthcare professionals can use the BeingBio CRP FIA Test to quickly determine the presence of inflammation. With a convenient cut-off level of 10 mg/L, this test helps identify elevated CRP levels, signaling an inflammatory response.
Important Note: While the BeingBio CRP FIA Test effectively detects inflammation, it does not pinpoint the underlying cause. Healthcare providers will use the test results in conjunction with a patient’s medical history, physical examination, and other diagnostic tests to determine the source and develop an appropriate treatment plan.
EUA No. 220205
Rapid Self-Test Kit for SARS-CoV-2 Antigens is an accurate and easy-to-use solution for detecting COVID-19 manufactured by Genabio.
This non-prescription test is designed for self-testing at home with anterior nasal swab specimens. It is authorized for individuals aged 14 years or older, or adult-collected samples from individuals aged 2 years or older within the first 7 days of symptom onset. With improved performance in detecting Omicron variants, this Rapid Self-Test Kit provides reliable results that US FDA authority has approved for EUA.
Each test includes a short nasal swab, buffer tube with drop cap, foil-sealed test cassette, and clear instructions. Results are available within 15 minutes. This test comes in sizes of 1 test/pack and 2 tests/pack, and the compact packaging reduces costs and is more environmentally friendly. Manufactured in ISO13485 accredited Genabio facilities.
FDA EUA Approved (No. EUA240006)
This test is authorized for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B protein antigens. This test is authorized for non-prescription home use with self-collected anterior nasal swab specimens from individuals aged 14 years or older, or with adult-collected anterior nasal swab specimens from individuals two (2) years or older.
Stay ahead of the curve and ensure your health with our latest Tyfast Flu A/B & COVID-19 Multiplex Rapid Home Test Kit (OTC options). This state-of-the-art rapid test empowers you to quickly check for both flu (A & B) and COVID-19 infection from the comfort of your home in just 10 minutes. Perfect for anyone experiencing symptoms of respiratory diseases, our kit offers peace of mind with swift and accurate results.
The BeingBio RealTime High-Risk HPV kit is suitable for in vitro qualitative detection of 14 high-risk types of human papillomavirus (including HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 66) nucleic acid material DNA in female cervical cell samples, and genotyping detection of HPV16 and HPV18 among them.
BeingBio Multiplex Real Time PCR Kit for HPV High-Risk Gene-type Screen kit is suitable for the detection of human papillomavirus (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) DNA typing in female cervical exfoliated cells. The kit is used for the auxiliary diagnosis of human papillomavirus infection, and can identify the specific types of human papillomavirus in each group. The test results of the kit are for clinical reference only and should not be used as the sole basis for diagnosis or exclusion.
BeingBio Freeze-Dried Multiplex Real Time PCR Kit for Mycoplasma hominis / Mycoplasma genitalium kit was used for qualitative detection of Mycoplasma hominis (MH) and Mycoplasma genitalium (MG) nucleic acid reproductive tract secretions samples. It can be used for aided diagnosis of MH and MG.
BeingBio Freeze-Dried Multiplex Real Time PCR Kit for Types 6 and 11 of HPV is intended for use as qualitative detection of Types 6 and 11 of HPV nucleic acid in cervical swab samples of suspected cases of HPV infection, suspected cluster cases, and others for the diagnosis or differential diagnosis of HPV infection.
BeingBio Freeze-Dried Multiplex Real Time PCR Kit for Streptococcus pneumonia / mycoplasma pneumonia kit is suitable for qualitative detection of Streptococcus pneumonia (SP) and Mycoplasma Pneumonia (MP) in sputum or throat swabs samples of patients. It can be used for auxiliary diagnosis of mycoplasma pneumonia and streptococcus pneumonia.
INTENDED USE
Monkeypox Virus Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human rash exudates and blood samples.
MATERIALS PROVIDED
• Monkeypox Virus Ag Test
• Instructions Sheet
• Pipette
• Swab
• Treatment tube containing sample treatment solution
• Buffer solution
